Despite ketamine-assisted therapy being approved for treating several mental health conditions, it's generally not covered by insurance or employers. Though that likely won't always be the case, as psychedelics gather more research and employers notice the benefits for their workplaces.
About 73% of benefits leaders believe their company has increased employee mental health support, a new survey found. Yet, many managers and employees disagree, showing a disconnect in perceptions.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Brightline’s services are now available to all of Evernorth’s employer clients across all 50 states, as well as Cigna’s customers who receive health coverage through their employer or marketplace exchange plans. These services include educational content about mental health concerns, interactive exercises, one-on-one coaching and care with therapists and psychiatrists.
INVI MindHealth, which was created by a former Navy SEAL, is a new mental health app that aims to support veterans. The idea for the app was born out CEO Jonathan Wilson's own struggles with mental health after leaving the service.
Talkspace's new product, Talkspace Engage, aims to help employers promote their mental health benefits to their employees. It allows employers to easily share mental health resources and virtual classes led by Talkspace clinicians.
Cognoa's Canvas Dx product is authorized by the Food and Drug Administration and assists healthcare providers in diagnosing autism spectrum disorder for children ages 18 months through 72 months. Members of Health Transformation Alliance can now add Canvas Dx to their benefit plans.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
The Health Affairs study found that in 2006, 10.7% of primary care visits addressed mental health concerns, compared 15.9% by 2016 and 2018, representing a 50% increase.
Suicide-related diagnoses in children and adolescents increased 14% since before the pandemic, a new Evernorth analysis shows. Female and Asian/Pacific Islander youth are especially struggling.
ReKlame Health launched in 2020 to provide affordable, culturally competent behavioral healthcare to Black and Brown communities in New York. On Monday, the startup announced it is now serving patients in two additional states — New Jersey and Florida.
London-based Unmind offers a measurement tool that allows employees to gain insights into their own mental health. Its content library also provides access to exercises and self-guided courses. Dublin-based Frankie Health, meanwhile, connects employees to a global network of mental health practitioners. The combined organization's new product, Unmind Talk, joins the strengths of both companies.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Season one focusing on chronic disease management kicks off with a conversation with Stephanie Tilenius, CEO of Vida Health that aims to treat both the mind and the body.
Less than 20% of behavioral healthcare providers collect data on how patients are progressing with their treatment. To buck this trend, Two Chairs is rolling out “mental health snapshots,” which are consistent summaries of patients’ well-being designed to offer real-time insight to both clinicians and clients.
The new company is called Lucet and was created out of the 2022 merger between New Directions Behavioral Health and Tridiuum. Lucet unveiled its solution called Navigate & Connect, which helps connect health plan members to behavioral health care.
There are several trends to watch out for in the substance use disorder space in 2023, according to CHESS Health's CEO Hans Morefield. These trends include rising addiction rates and increased comfort in virtual health.
Several experts look for mental health startups that have conducted rigorous randomized controlled trials. Some of these companies include Ginger, Calm and Woebot.